PL371310A1 - Zastosowanie podstawionych 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-onów do wytwarzania środków leczniczych o działaniu hamującym wobec lipazy trzustkowej - Google Patents

Zastosowanie podstawionych 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-onów do wytwarzania środków leczniczych o działaniu hamującym wobec lipazy trzustkowej

Info

Publication number
PL371310A1
PL371310A1 PL03371310A PL37131003A PL371310A1 PL 371310 A1 PL371310 A1 PL 371310A1 PL 03371310 A PL03371310 A PL 03371310A PL 37131003 A PL37131003 A PL 37131003A PL 371310 A1 PL371310 A1 PL 371310A1
Authority
PL
Poland
Prior art keywords
oxdiazole
alkoxy
phenyl
substituted
pancreatic lipase
Prior art date
Application number
PL03371310A
Other languages
English (en)
Inventor
Karl Schoenafinger
Stefan Petry
Güunter Müller
Armin Bauer
Hubert Otto Heuer
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of PL371310A1 publication Critical patent/PL371310A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL03371310A 2002-02-28 2003-02-17 Zastosowanie podstawionych 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-onów do wytwarzania środków leczniczych o działaniu hamującym wobec lipazy trzustkowej PL371310A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10208986A DE10208986A1 (de) 2002-02-28 2002-02-28 Verwendung substituierter 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one zur Herstellung von Arzneimitteln mit hemmender Wirkung an der pankreatischen Lipase

Publications (1)

Publication Number Publication Date
PL371310A1 true PL371310A1 (pl) 2005-06-13

Family

ID=27740557

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03371310A PL371310A1 (pl) 2002-02-28 2003-02-17 Zastosowanie podstawionych 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-onów do wytwarzania środków leczniczych o działaniu hamującym wobec lipazy trzustkowej

Country Status (20)

Country Link
EP (1) EP1482929A1 (pl)
JP (1) JP2005519079A (pl)
KR (1) KR20040101250A (pl)
CN (1) CN1638766A (pl)
AR (1) AR038702A1 (pl)
AU (1) AU2003210292A1 (pl)
BR (1) BR0308045A (pl)
CA (1) CA2477005A1 (pl)
CO (1) CO5611144A2 (pl)
DE (1) DE10208986A1 (pl)
HR (1) HRP20040783A2 (pl)
HU (1) HUP0500093A2 (pl)
IL (1) IL163719A0 (pl)
MA (1) MA27173A1 (pl)
MX (1) MXPA04007480A (pl)
NO (1) NO20044091L (pl)
PL (1) PL371310A1 (pl)
RU (1) RU2004128932A (pl)
TW (1) TW200400026A (pl)
WO (1) WO2003072098A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5080970B2 (ja) 2004-06-17 2012-11-21 サイトキネティクス・インコーポレーテッド 心疾患を治療するための置換尿素誘導体
AU2005298692A1 (en) 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type I, obesity and related conditions
TW200808321A (en) 2005-12-15 2008-02-16 Cytokinetics Inc Certain chemical entities, compositions and methods
US7825120B2 (en) 2005-12-15 2010-11-02 Cytokinetics, Inc. Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
EP1962852B1 (en) 2005-12-19 2017-01-25 Cytokinetics, Inc. Compounds, compositions and methods
CA2708447C (en) * 2007-12-25 2016-05-10 Kissei Pharmaceutical Co., Ltd. Novel catechol derivative, pharmaceutical composition containing the same, use of the catechol derivative, and use of the pharmaceutical composition
AR074978A1 (es) 2008-12-23 2011-03-02 Bial Portela & Ca Sa 3-n-aril-1,3,4-oxadiazolonas 5-o-sustituidas para uso en el tratamiento del dolor y procedimiento de obtencion
CN103086859B (zh) * 2011-11-08 2015-11-11 清华大学 2,4-二羟基-5,6-取代-1-卤代苯衍生物、其合成方法及其应用
CN111527065B (zh) * 2017-09-01 2024-05-07 科廷大学 油酰基-溶血磷脂酰肌醇(油酰基-lpi)的合成衍生物及其用途
CN109879839B (zh) * 2019-03-12 2023-04-25 沈阳大学 6-哌嗪甲基-7-羟基苯并呋喃类化合物及其医药用途
PH12022552021A1 (en) * 2020-02-07 2024-02-05 Cytokinetics Inc Nampt modulators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
RU2281283C2 (ru) * 2000-03-07 2006-08-10 Санофи-Авентис Дойчланд Гмбх Замещенные 3-фенил-5-алкокси-1,3,4-оксадиазол-2-оны и их применение для ингибирования гормоночувствительной липазы

Also Published As

Publication number Publication date
CO5611144A2 (es) 2006-02-28
NO20044091L (no) 2004-09-27
BR0308045A (pt) 2004-12-21
EP1482929A1 (de) 2004-12-08
IL163719A0 (en) 2005-12-18
CA2477005A1 (en) 2003-09-04
HUP0500093A2 (hu) 2005-04-28
RU2004128932A (ru) 2005-04-10
AU2003210292A1 (en) 2003-09-09
WO2003072098A1 (de) 2003-09-04
CN1638766A (zh) 2005-07-13
DE10208986A1 (de) 2003-09-11
TW200400026A (en) 2004-01-01
AR038702A1 (es) 2005-01-26
HRP20040783A2 (en) 2005-04-30
MA27173A1 (fr) 2005-01-03
JP2005519079A (ja) 2005-06-30
MXPA04007480A (es) 2004-11-10
KR20040101250A (ko) 2004-12-02

Similar Documents

Publication Publication Date Title
ZA200500086B (en) Novel carboxamide compounds having an MCH-antagonistic effect, medicaments containing said compounds, and method for the production thereof
HUP0500851A3 (en) Process for the preparation of rosuvastatin
ZA200408111B (en) Treatment of gastroparesis.
AU2003288023A1 (en) Process for the manufacture of 1,2-epoxy-3-chloropropane
IL165973A0 (en) Method for the treatment of multiple sclerosis
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
GB2406812B (en) Production system for the manufacture of products
WO2003037863A3 (de) Substituierte indole, verfahren zu deren herstellung und deren verwendung zur schmerzbekämpfung
PL371310A1 (pl) Zastosowanie podstawionych 3-fenylo-5-alkoksy-1,3,4-oksadiazol-2-onów do wytwarzania środków leczniczych o działaniu hamującym wobec lipazy trzustkowej
IL158400A0 (en) Process for the production of citalopram
MXPA04004090A (es) Compuestos substituidos de 1h-quinolin-2-ona.
EP1467978A4 (en) "COMPOUNDS THAT CONTAIN VACCINATES DRUG LIPASE, THEIR SYNTHESIS AND USE"
AU2003258622A1 (en) Method for the production of $g(b)-carotinoids
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
PL371583A1 (pl) Sposób wytwarzania 7 alfa-metylosteroidów
AU2003266960A1 (en) Composition for the treatment of pain, especially for the treatment of articular pain
AU2003292209A8 (en) Method for the production of optically active dihydropyrones
GB0201025D0 (en) The treatment of degenerative diseases
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
AU2003215298A1 (en) Alpha1beta1 antagonists for treatment of atherosclerosis
AU2003224495A1 (en) Process for the preparation of enantiomerically enriched compounds
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2003209534A1 (en) The method of treating tuberculosis
AU2003267541A1 (en) Method for the production of substituted trifluoroethylenes

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)